Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03632928
Other study ID # 002
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 2018
Est. completion date March 2019

Study information

Verified date August 2018
Source Danish Headache Center
Contact Jeppe H Mann, MD
Phone +4538632684
Email jeppe.hvedstrup.mann@regionh.dk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim is to establish how headache and migraine can affect muscle hardness and tenderness in migraine patients


Description:

Migraine is a very common disorder, and many migraine patients have symptoms from their neck and muscles. 50% of migraine patients have a sensation of stiff neck in relation to migraine attacks. Furthermore it is well established, that migraine patients have tender muscles during migraine attack, which can be measured with pressure pain threshold.

In this study the investigators aim to establish the variation in ultrasound elastography and pressure pain threshold in migraine patients over time. And establish the significance of headache, migraine and prodromes on these measurements.

The study includes daily measurements of muscle hardness and muscle tenderness. The patients are asked to fulfill a headache diary and a short questionnaire asking about current headache, physical activity, stress and current infectious diseases. Sleep and physical activity is also measured objectively using a fitbit Charge2. Furthermore the patients are asked about symptoms which often are associated with migraine (prodromes).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 3
Est. completion date March 2019
Est. primary completion date January 2019
Accepts healthy volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Migraine Patient fulfilling international classification of headache disorders (ICHD 3) criteria

Exclusion Criteria:

- regular medication use other than medication for migraine or headache

- Other Pain disorders

- Musculoskeletal disorders affecting neck or upper body

Study Design


Intervention

Other:
Ultrasound Elastography
Measuring muscle hardness at the trapezius and neck bilateral
Pressure Pain threshold
Measuring Pressure pain threshold at the trapezius and neck bilateral

Locations

Country Name City State
Denmark Danish Headache Center Glostrup

Sponsors (1)

Lead Sponsor Collaborator
Danish Headache Center

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effect of migraine on muscle tenderness Muscle tenderness will be measured every day with pressure pain threshold. Migraine and headache is noted in a headache diary.
Is the next measurement of muscle tenderness after migraine attack higher than those with out temporal proximity to headache. (paired T-test)
Daily measurements for about 30-60 days in a row
Primary Effect of migraine on muscle hardness Muscle hardness will be measured every day with Ultrasound elastography. Migraine and headache is noted in a headache diary.
Is the next measurement of muscle tenderness after migraine attack higher than those with out temporal proximity to headache. (paired T-test)
Daily measurements for about 30-60 days in a row
Primary Regression analysis of muscle hardness Muscle hardness as the dependent variable and the following as the independent variables: Current migraine, Days until next migraine attack, days since last migraine attack, Sleep quality, physical activity, Stiff Neck (subjective feeling).
The result shows how much of the variability in muscle hardness that can be explained by the independent variables.
Daily measurements for about 30-60 days in a row
Primary Regression analysis of muscle tenderness Muscle tenderness as the dependent variable and the following as the independent variables: Current migraine, Days until next migraine attack, days since last migraine attack, Sleep quality, physical activity, stiff neck (subjective feeling).
The result shows how much of the variability in muscle hardness that can be explained by the independent variables.
Daily measurements for about 30-60 days in a row
Secondary Day to day variation of muscle hardness in non-headache days Muscle hardness will be measured every day with Ultrasound elastography. Migraine and headache is noted in a headache diary. Daily measurements for about 30-60 days in a row
Secondary Day to day variation of muscle tenderness in non-headache days Muscle tenderness will be measured every day with pressure pain threshold. Migraine and headache is noted in a headache diary. Daily measurements for about 30-60 days in a row
Secondary Prodromes in migraine patients assessed by self-reported questionnaires Descriptive data of how often migraine patients experience prodrome like symptoms Patients are every day asked of symptoms for the last 24 hours and current symptoms
Secondary Effect of tension type headache on muscle hardness Muscle hardness will be measured every day with Ultrasound elastography. Migraine and headache is noted in a headache diary.
Is the measurements performed on headache days higher than those with out temporal proximity to headache.
Daily measurements for about 30-60 days in a row
Secondary Effect of tension type headache on muscle tenderness. Muscle tenderness will be measured every day with pressure pain threshold. Migraine and headache is noted in a headache diary.
Is the measurements performed on headache days higher than those with out temporal proximity to headache.
Daily measurements for about 30-60 days in a row
See also
  Status Clinical Trial Phase
Completed NCT01432379 - BOTOX® Prophylaxis in Patients With Chronic Migraine
Completed NCT04084314 - Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study Phase 4
Recruiting NCT05048914 - Migraine Abortive Treatment
Completed NCT03662295 - Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
Completed NCT02766517 - Biomarker Study in Participants With Migraine Early Phase 1
Completed NCT00963937 - Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents Phase 3
Completed NCT02559895 - A Multicenter Assessment of ALD403 in Frequent Episodic Migraine Phase 3
Completed NCT01435941 - Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine N/A
Completed NCT00743015 - Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks Phase 1
Completed NCT01376141 - Drug Use Investigation for IMIGRAN Tablet N/A
Completed NCT02183688 - Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients Phase 3
Completed NCT06061588 - "Potential Effects of Virtual Reality Technology on the Treatment of Migraine-Type Headaches" N/A
Completed NCT03588364 - The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine N/A
Completed NCT04091321 - Association Between Chronic Headache and Back Pain With Childbirth
Completed NCT00385008 - TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine Phase 3
Active, not recruiting NCT05888298 - Proximal and Distal Approach GON RFT in Migraine N/A
Completed NCT03435185 - Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients N/A
Recruiting NCT06459635 - Migraine Attack Pain Phase Prediction Study
Completed NCT02565186 - An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine Phase 3
Completed NCT05658185 - Migraine Difficult to Treat: the Importance of Psychological Care in the Chronic Patient N/A